Invesco Ltd. Rhythm Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 302,846 shares of RYTM stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

302,846

Previous 264,417 14.53%

Holding current value

$17.5 Million

Previous $13.9 Million 22.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$46.91 - $67.33 $1.8 Million - $2.59 Million	38,429 Added 14.53%	302,846 $16.9 Million
Q3 2024 Nov 12, 2024	SELL	$40.81 - $55.0 $501,269 - $675,565	-12,283 Reduced 4.44%	264,417 $13.9 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $6.67 Million - $8.36 Million	188,495 Added 213.7%	276,700 $11.4 Million
Q1 2024 May 14, 2024	SELL	$39.12 - $52.44 $1.86 Million - $2.49 Million	-47,526 Reduced 35.01%	88,205 $3.82 Million
Q4 2023 Feb 12, 2024	BUY	$21.39 - $49.64 $2.3 Million - $5.33 Million	107,357 Added 378.36%	135,731 $6.24 Million
Q3 2023 Nov 13, 2023	BUY	$15.81 - $27.8 $1,549 - $2,724	98 Added 0.35%	28,374 $650,000
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $461,464 - $598,037	28,276 New	28,276 $466,000
Q4 2022 Feb 13, 2023	BUY	$22.21 - $30.25 $7.42 Million - $10.1 Million	334,273 New	334,273 $9.73 Million
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $51,501 - $202,210	-16,507 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $47,452 - $94,749	-7,741 Reduced 31.92%	16,507 $190,000
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $26,592 - $42,881	-3,085 Reduced 11.29%	24,248 $243,000
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $23,652 - $41,958	2,025 Added 8.0%	27,333 $357,000
Q2 2021 Aug 17, 2021	BUY	$18.52 - $22.55 $150,030 - $182,677	8,101 Added 47.08%	25,308 $495,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $52,548 - $102,476	2,595 Added 17.76%	17,207 $366,000
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $98,398 - $151,571	4,648 Added 46.65%	14,612 $434,000
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $3,082 - $5,203	-170 Reduced 1.68%	9,964 $216,000
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $14,309 - $25,172	-993 Reduced 8.92%	10,134 $226,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $146,431 - $254,808	11,127 New	11,127 $169,000

Others Institutions Holding RYTM

# of Institutions

213

Shares Held

64.4M

Call Options Held

445K

Put Options Held

26.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.21B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account